Please consider downloading the latest version of Internet Explorer
to experience this site as intended.
Tools Search Main Menu

Tag: Wilmot Cancer Institute

How can a single gene be at fault in one of the deadliest cancers?

How can a single gene be at fault in one of the deadliest cancers?

October 15, 2018

A breakthrough study from Rochester’s Wilmot Cancer Institute gives researchers hope that new gene-targeted therapies could improve survival rates for acute myeloid leukemia, which have not budged in years.

Continue Reading

Research is changing the game for melanoma treatment

Research is changing the game for melanoma treatment

February 1, 2018

Some Wilmot Cancer Institute patients with advanced melanoma may have longer disease-free survival thanks to new drug treatment options tested by Rochester researchers.

Continue Reading

Pancreatic tumors may require a one-two-three punch

Pancreatic tumors may require a one-two-three punch

January 15, 2018

Wilmot Cancer Institute scientists have discovered that a three-drug combination can simultaneously target the cancer cells as well as the other harmful, inflammatory cells within the tumor.

Continue Reading

Newest data links inflammation to chemo-brain

Newest data links inflammation to chemo-brain

December 14, 2017

Chemo-brain, or cancer-related cognitive impairment, is estimated to impact 80 percent of people in treatment. A new Medical Center study shows that inflammation in the blood plays a key role.

Continue Reading

Rochester positioned among first to offer FDA approved cancer therapy

Rochester positioned among first to offer FDA approved cancer therapy

October 20, 2017

UR Medicine’s Wilmot Cancer Institute will be among the first sites in the world to offer CAR T-cell therapy —a new type of immunotherapy approved this week by the FDA—to adults with aggressive lymphoma. The engineered gene therapy has been described as a revolutionary “living drug” and one of the most powerful cancer treatments to emerge in recent years.

Continue Reading

Can the sunshine vitamin help lymphoma patients?

Can the sunshine vitamin help lymphoma patients?

July 19, 2017

A new $3 million grant to the Wilmot Cancer Institute allows oncologists to evaluate whether adding vitamin D to standard therapy will help cancer patients live longer.

Continue Reading

Study points to new way to slow cancer cell growth

Study points to new way to slow cancer cell growth

May 25, 2017

Researchers from the Center for RNA Biology have identified a new way to potentially slow the fast-growing cells that characterize all types of cancer.

Continue Reading

Scientists light the way for immune system to attack cancer

Scientists light the way for immune system to attack cancer

May 15, 2017

The science behind harnessing the immune system to fight cancer is complicated, but a Medical Center laboratory discovered a simple, practical way to use light and optics to steer killer immune cells toward tumors.

Continue Reading

Exercise beats medication in fighting cancer fatigue

Exercise beats medication in fighting cancer fatigue

March 2, 2017

Exercise or psychological therapy work better than medications to reduce cancer-related fatigue and should be recommended first to patients, according to a Wilmot Cancer Institute–led study published in JAMA Oncology.

Continue Reading

Chemo-brain among women with breast cancer is pervasive, study shows

Chemo-brain among women with breast cancer is pervasive, study shows

December 28, 2016

The largest study to date of memory and cognition problems related to chemotherapy shows that women with breast cancer report substantial issues lasting as long as six months after treatment.

Continue Reading